Bellevue Healthcare Trust plc has published its Annual Report and Accounts 2025 for the year ended 30 November 2025. The report outlines that the trust is a long-only investment trust focused on listed or quoted global healthcare equities, and notes that performance over the reporting period lagged its comparator index, with the share price return supported by a narrowing discount to net asset value. The report also details a strategic review initiated during the year in response to sustained underperformance and a reduction in the company’s size. Following this process, the board announced its intention to appoint Columbia Threadneedle Investments as the trust’s alternative investment fund manager and investment manager, subject to shareholder approval after the financial year end, alongside proposed changes to investment policy, discount management arrangements and the introduction of periodic liquidity events. The report further notes the use of share buybacks during the year as part of discount management and provides updates on board succession plans linked to the proposed management change. The full report can be accessed through the link below.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bellevue Healthcare Trust plc published the original content used to generate this news brief on March 02, 2026, and is solely responsible for the information contained therein.
Comments